Kenya

Quality-Assured Pharmacies Improving Healthcare for People with Low Incomes in Kenya

Pharmnet® joins BCtA with a commitment to increase number and reach of accredited pharmacies
Press Release

New York/Nairobi, June 17, 2016 /3BL Media/ – Pharmnet®, a franchise network of licensed private pharmacies, has joined the Business Call to Action with a commitment to engage 3,000 pharmacies in its quality-assured network and train 9,000 pharmacy staff by 2017. The network will also provide business skills training to 3,000 pharmacy owners in order to help them build and run their pharmacies profitably.

International Women’s Day: Making a Difference

“My heart still cries for those women and children in Kenya even though I am miles apart.”
Blog

Native Kenyan given second chance for global outreach

As a child and young adult in her native Kenya, TransCanada’s Pauline Ngure witnessed the heartbreak inflicted on young girls.

She grew up among neighbours and friends who discriminated by gender — daughters were treated as “second class” members while sons were given “priority,” says Ngure, an associate in Supply Chain Operations.

First Novartis Access Treatments Delivered to Kenya

Shipment includes medicines against cardiovascular diseases, diabetes, respiratory conditions and breast cancer
Article

We are pleased to announce that the first Novartis Access shipment has just been delivered to Kenya. This shipment includes medicines against cardiovascular diseases, diabetes, respiratory conditions and breast cancer. The medicines are currently stored in the MEDS warehouse (Mission for Essential Drugs and Supplies) in Nairobi. MEDS is a faith-based not-for-profit medical supply chain and capacity building organization in Kenya.

IBM Launching Teacher TryScience in Kenya

Article

The Ministry of Education and Science in Kenya recently launched the national roll out of Teachers TryScience. This is hugely significant for Kenya where they note that "The future prosperity of Kenya depends on young people choosing STEM related subjects." Currently only 2% of students study STEM subjects at tertiary level.

World Wildlife Fund Opens Kenya Safari Sweepstakes

One grand prize winner will receive an exclusive, custom seven-day safari for two in Kenya provided by Natural Habitat Adventures
Press Release

November 4, 2015 /3BL Media/ - World Wildlife Fund (WWF) announced today a sweepstakes for a seven-day/six-night safari to the famed Maasai Mara National Reserve in Kenya. This experience is custom-designed by Natural Habitat Adventures for the sweepstakes and not available anywhere else.

The sweepstakes aims to raise awareness for the efforts of WWF and on-the-ground partners in Kenya, who have worked together for years to protect elephants, rhinos and other wildlife by fighting illegal wildlife trade, minimizing human-wildlife conflict, and protecting critical habitat.

Fighting Hunger from the Ground Up

By Mark Edge, Water Efficient Maize for Africa Partnership Lead at Monsanto
Blog

Imagine if a lack of rainfall stood between you and your ability to feed your children.

For millions of families around the world, this is a daily reality. And for family farmers from Kansas to Kenya, drought and pests can mean the difference between a bountiful harvest and a meager one that compromises their ability to put food on their tables … and ours.

Kenya First Country to Launch ‘Novartis Access’, Expanding Affordable Treatment Options Against Chronic Diseases

Program supports Kenyan government on non-communicable disease (NCD) prevention and control – by 2030, NCDs are expected to cause more than 60% of deaths in the country
Summary: 

•    Novartis Access is a first-of-its-kind portfolio of products aimed at increasing access to medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer in low- and low-middle-income countries
•    Program supports Kenyan government on non-communicable disease (NCD) prevention and control – by 2030, NCDs are expected to cause more than 60% of deaths in the country1
•    Agreements signed with Kenyan government and NGOs include programs to distribute medicines, raise disease awareness and strengthen healthcare system capabilities in key NCDs 

Press Release

•    Novartis Access is a first-of-its-kind portfolio of products aimed at increasing access to medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer in low- and low-middle-income countries
•    Program supports Kenyan government on non-communicable disease (NCD) prevention and control – by 2030, NCDs are expected to cause more than 60% of deaths in the country1
•    Agreements signed with Kenyan government and NGOs include programs to distribute medicines, raise disease awareness and strengthen healthcare system capabilities in key NCDs 

Two-Year Joint Collaboration With Malaria No More Helps Keep Moms And Babies Safe Through Medical Treatments And Nationwide Awareness Campaign

Summary: 

For nearly two years, Kimberly-Clark, our Huggies brand in Kenya and the nonprofit, Malaria No More’s Mothers Against Malaria Campaign have worked together to increase malaria awareness and keep children and families safe from deadly mosquito bites that claim the lives of 453,000 children per year— 90% of those in Africa. 

Article

For nearly two years, Kimberly-Clark, our Huggies brand in Kenya and the nonprofit, Malaria No More’s Mothers Against Malaria Campaign have worked together to increase malaria awareness and keep children and families safe from deadly mosquito bites that claim the lives of 453,000 children per year— 90% of those in Africa. 

Novartis Launches ‘Novartis Access’, a Portfolio of Affordable Medicines to Treat Chronic Diseases in Lower-income Countries

First-of-its-kind portfolio approach in healthcare industry, aiming to increase availability and affordability of 15 medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer
Summary: 
  • First-of-its-kind portfolio approach in healthcare industry, aiming to increase availability and affordability of 15 medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer
  • Novartis portfolio to be offered to governments and non-governmental organizations in low- and low-middle-income countries for USD 1 per treatment, per month
  • Some 28 million people die from chronic diseases in low- and middle-income countries each year, representing 75% of such deaths globally1
Press Release
  • First-of-its-kind portfolio approach in healthcare industry, aiming to increase availability and affordability of 15 medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer
  • Novartis portfolio to be offered to governments and non-governmental organizations in low- and low-middle-income countries for USD 1 per treatment, per month
  • Some 28 million people die from chronic diseases in low- and middle-income countries each year, representing 75% of such deaths globally1

Pages

Subscribe to Kenya